The American Thyroid Association (ATA) today announced today announced that Nancy Carrasco, MD, of the Yale School of Medicine, will deliver the plenary lecture on Sept. 20 at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
An international community of researchers, clinicians and health care professionals will convene at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada, held Sept. 19 – Sept. 23, to present and discuss today’s most promising clinical, translational, and basic science research focused on thyroid diseases and disorders.
The American Thyroid Association (ATA) today announced that its Alliance for Patient Education will host a public health forum, “Thyroid Disease and You,” as part of the 82nd ATA Annual Meeting, in Québec City, Québec, Canada. This free event will be held on Saturday, Sept. 22, from 1:00-2:00 p.m., at the Hilton Quebec and is open to the general public.
The American Thyroid Association today released a policy statement aiming to inform the public and healthcare practitioners about how to minimize risks to the thyroid gland associated with radiation exposure from diagnostic medical and dental radiography.
May 25th is World Thyroid Day, dedicated to all thyroid patients, to those who provide care and education to them and to the investigators whose discoveries help improve the treatment of patients with thyroid diseases.
ATA leader, Richard T. Kloos, M.D., and professor of medicine at Ohio State University School of Medicine joins molecular diagnostics company.
Dr. Elizabeth Pearce, Associate Professor of Medicine at Boston University School of Medicine, today delivered the Van Meter Award Lecture at its 81st Annual Meeting, held October 26-30, Indian Wells, California.
Data presented today at the 81st Annual Meeting of the American Thyroid Association showed significantly fewer patients (51% versus 71%) were considered to be at high risk for OSA following surgical reduction or removal of the thyroid gland.
Glitazones, a class of PPARg drugs capable of re-differentiating the cancer cells, can boost efficacy of radioiodine therapy in metastatic thyroid cancer.
The American Thyroid Association (ATA) will bestow the 2011 John B. Stanbury Pathophysiology Medal to Basil Rapoport, MB, ChB, Professor and Director of the Autoimmune Disease Unit at Cedars-Sinai Medical Center, in Los Angeles, California, and Professor of Medicine in residence at University of California – Los Angeles. The award recognizes the impact that Dr. Rapoport’s research has had on research and clinical practice related to thyroid disease.
The American Thyroid Association has selected Bryan R. Haugen, MD, as its new President-elect, and Martha A. Zeiger, MD, and Erik K. Alexander, MD, as the newest members of its Board of Directors. Former ATA President-elect, James A. Fagin, MD, was named president of the ATA, and Secretary-elect John C. Morris, MD, PhD, was named Secretary/Chief Operating Officer of the ATA.
A new era of leadership begins at the American Thyroid Association (ATA), with the inauguration of its new president, James A. Fagin, MD, and new secretary/chief operating officer (COO), John C. Morris, MD, who today assumed their new positions at the 81st Annual Meeting of the ATA, October 26-30, 2011.
Researchers are exploring a novel therapeutic approach intended to modify the genetic make-up of radioiodine-refractory forms of thyroid cancer to make them more susceptible to the anti-cancer effects of radioiodine therapy.
Researchers have developed a new, rapid method for direct detection of the BRAF V600E gene in thyroid tissue without the need to purify DNA from tumor cells--high resolution melting analysis (HRM).
Universal screening for autoimmune thyroid disease in the first trimester of pregnancy is cost-effective compared with screening of only high-risk women. Both the risk-based and universal screening options are cost-effective when relative to no screening.
Researchers tested the effectiveness of lenvatinib in patients with advanced, progressive differentiated thyroid cancer (DTC) that does not respond to conventional radioiodine therapy. Data demonstrated a partial response in 45%-50% of the 58 patients enrolled in the study.
– Individuals with advanced papillary thyroid cancer (PTC) that are associated with the BRAFV600E gene mutation have a higher risk of recurrent disease and progression to more advanced, poorly differentiated thyroid cancer, according to data presented today at the 81st Annual Meeting of the American Thyroid Association (ATA).
The American Thyroid Association will present an honorarium to E. Chester “Chip” Ridgway, MD, the 2011 recipient of the Lewis E. Braverman Lectureship Award, on October 29, 2011, at its 81st Annual Meeting, held October 26-30 in Indian Wells, California.
This year’s Sidney H. Ingbar Distinguished Lectureship Award recipient is Gregory Brent, MD, Professor of Medicine and Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, and Chief, Endocrinology and Diabetes Division, VA Greater Los Angeles Healthcare System. He will receive this Award on October 28, 2011, at the 81st Annual Meeting of the ATA, in Indian Wells, California.
Dr. David S. Cooper, MD, will deliver the Paul Starr Award Lecture, entitled “The Medical Treatment of Hyperthyroidism: Past, Present, and Future” at the 81st annual meeting of the American Thyroid Association on Thursday, October 27 at 1:30 pm.
A diverse community of physicians, researchers, and health care professionals will gather October 26-30, 2011, in Indian Wells, California, to participate in and benefit from the wealth of scientific and medical expertise and educational, networking, and professional development opportunities available during the 81st Annual Meeting of the American Thyroid Association (ATA).
The 81st Annual Meeting of the American Thyroid Association (ATA) feature Plenary Lectures by Margaret S. Pepe, PhD, University of Washington's Fred Hutchinson Cancer Research Center, and Pat Zanzonico, PhD, Memorial Sloan-Kettering Cancer Center.
Thyroid Research Grant Awardees announced by the American Thyroid Association.
New clinical guidelines developed by an expert panel that include 100 evidence-based recommendations for optimal care of patients with hyperthyroidism and other causes of thyrotoxicosis are presented in the current issue of Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc.
World Thyroid Day sets goals: 1. Increase awareness of thyroid health; 2. Promote understanding of advances made in treating thyroid diseases; 3. Emphasize the prevalence of thyroid diseases; 4. Focus on the urgent need for education and prevention programs; and 5. Expand awareness of new treatment modalities.
Members of the American Thyroid Association concerned about a proposal to reduce salt in the diet to improve cardiac disease rates caution that such a reduction would also reduce iodine intake.
The American Thyroid Association and the European Thyroid Association support World Thyroid Day, May 25, 2010, to enhance awareness and understanding of thyroid health.
At its Spring Meeting in Minneapolis, Minnesota (May13-16), The American Thyroid Association has presented awards to long-time members Drs. Charles Emerson and Terry F. Davies.
New approaches to thyroid diseases are necessary to confront rising thyroid disease rates. Internationally recognized thyroid disease experts will meet to discuss “Thyroid Disorders in the Era of Personalized Medicine.”
At the ATA's Spring Meeting, thyroidologists will present new research to both confront the rise in thyroid diseases and create new and better ways to treat thyroid diseases in an era of "personalized medicine."
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right